APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmology Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ophthalmology Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchOphthalmology Therapeutics Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmology Therapeutics Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Ophthalmology Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmology Therapeutics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmology Therapeutics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Ophthalmology Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmology Therapeutics include Teva Pharmaceutical Industries, Novartis AG, Pfizer, Santen Pharmaceutical, Bayer, AbbVie, Regeneron Pharmaceuticals, Otsuka Holdings and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmology Therapeutics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmology Therapeutics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmology Therapeutics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmology Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmology Therapeutics Segment by Company

Teva Pharmaceutical Industries

Novartis AG

Pfizer

Santen Pharmaceutical

Bayer

AbbVie

Regeneron Pharmaceuticals

Otsuka Holdings

F. Hoffmann-La Roche

Aerie Pharmaceuticals

Ophthalmology Therapeutics Segment by Type

Ointments

Eye Solutions

Gels

Capsules & Tablets

Ophthalmology Therapeutics Segment by Application

Eye Infection

Glaucoma

Dry Eye Syndrome

Other

Ophthalmology Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmology Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmology Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmology Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmology Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmology Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ophthalmology Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ophthalmology Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ophthalmology Therapeutics Industry Trends Table 2. Ophthalmology Therapeutics Industry Drivers Table 3. Ophthalmology Therapeutics Industry Opportunities and Challenges Table 4. Ophthalmology Therapeutics Industry Restraints Table 5. Global Ophthalmology Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ophthalmology Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ophthalmology Therapeutics Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Ophthalmology Therapeutics Sales Market Share by Manufacturers Table 9. Global Ophthalmology Therapeutics Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Ophthalmology Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ophthalmology Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ophthalmology Therapeutics Manufacturers, Product Type & Application Table 13. Global Ophthalmology Therapeutics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmology Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ointments Table 17. Major Manufacturers of Eye Solutions Table 18. Major Manufacturers of Gels Table 19. Major Manufacturers of Capsules & Tablets Table 20. Global Ophthalmology Therapeutics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 22. Global Ophthalmology Therapeutics Sales by Type (2027-2032) & (k units) Table 23. Global Ophthalmology Therapeutics Sales Market Share by Type (2021-2026) Table 24. Global Ophthalmology Therapeutics Sales Market Share by Type (2027-2032) Table 25. Global Ophthalmology Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Ophthalmology Therapeutics Revenue by Type (2021-2026) & (k units) Table 27. Global Ophthalmology Therapeutics Revenue by Type (2027-2032) & (k units) Table 28. Global Ophthalmology Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Ophthalmology Therapeutics Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Eye Infection Table 31. Major Manufacturers of Glaucoma Table 32. Major Manufacturers of Dry Eye Syndrome Table 33. Major Manufacturers of Other Table 34. Global Ophthalmology Therapeutics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 36. Global Ophthalmology Therapeutics Sales by Application (2027-2032) & (k units) Table 37. Global Ophthalmology Therapeutics Sales Market Share by Application (2021-2026) Table 38. Global Ophthalmology Therapeutics Sales Market Share by Application (2027-2032) Table 39. Global Ophthalmology Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Ophthalmology Therapeutics Revenue by Application (2021-2026) & (k units) Table 41. Global Ophthalmology Therapeutics Revenue by Application (2027-2032) & (k units) Table 42. Global Ophthalmology Therapeutics Revenue Market Share by Application (2021-2026) Table 43. Global Ophthalmology Therapeutics Revenue Market Share by Application (2027-2032) Table 44. Global Ophthalmology Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Ophthalmology Therapeutics Sales by Region (2021-2026) & (k units) Table 46. Global Ophthalmology Therapeutics Sales Market Share by Region (2021-2026) Table 47. Global Ophthalmology Therapeutics Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Ophthalmology Therapeutics Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 51. North America Ophthalmology Therapeutics Sales by Country (2027-2032) & (k units) Table 52. Europe Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 54. Europe Ophthalmology Therapeutics Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Ophthalmology Therapeutics Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Ophthalmology Therapeutics Sales by Country (2027-2032) & (k units) Table 61. Global Ophthalmology Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Ophthalmology Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Ophthalmology Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Ophthalmology Therapeutics Revenue Market Share by Region (2021-2026) Table 65. Global Ophthalmology Therapeutics Revenue Market Share by Region (2027-2032) Table 66. Teva Pharmaceutical Industries Company Information Table 67. Teva Pharmaceutical Industries Business Overview Table 68. Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Portfolio Table 70. Teva Pharmaceutical Industries Recent Development Table 71. Novartis AG Company Information Table 72. Novartis AG Business Overview Table 73. Novartis AG Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Novartis AG Ophthalmology Therapeutics Product Portfolio Table 75. Novartis AG Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pfizer Ophthalmology Therapeutics Product Portfolio Table 80. Pfizer Recent Development Table 81. Santen Pharmaceutical Company Information Table 82. Santen Pharmaceutical Business Overview Table 83. Santen Pharmaceutical Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Santen Pharmaceutical Ophthalmology Therapeutics Product Portfolio Table 85. Santen Pharmaceutical Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Bayer Ophthalmology Therapeutics Product Portfolio Table 90. Bayer Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Business Overview Table 93. AbbVie Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. AbbVie Ophthalmology Therapeutics Product Portfolio Table 95. AbbVie Recent Development Table 96. Regeneron Pharmaceuticals Company Information Table 97. Regeneron Pharmaceuticals Business Overview Table 98. Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Portfolio Table 100. Regeneron Pharmaceuticals Recent Development Table 101. Otsuka Holdings Company Information Table 102. Otsuka Holdings Business Overview Table 103. Otsuka Holdings Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Otsuka Holdings Ophthalmology Therapeutics Product Portfolio Table 105. Otsuka Holdings Recent Development Table 106. F. Hoffmann-La Roche Company Information Table 107. F. Hoffmann-La Roche Business Overview Table 108. F. Hoffmann-La Roche Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. F. Hoffmann-La Roche Ophthalmology Therapeutics Product Portfolio Table 110. F. Hoffmann-La Roche Recent Development Table 111. Aerie Pharmaceuticals Company Information Table 112. Aerie Pharmaceuticals Business Overview Table 113. Aerie Pharmaceuticals Ophthalmology Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Aerie Pharmaceuticals Ophthalmology Therapeutics Product Portfolio Table 115. Aerie Pharmaceuticals Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Ophthalmology Therapeutics Distributors List Table 119. Ophthalmology Therapeutics Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Ophthalmology Therapeutics Product Image Figure 2. Global Ophthalmology Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmology Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmology Therapeutics Sales (2021-2032) & (k units) Figure 5. Global Ophthalmology Therapeutics Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ophthalmology Therapeutics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ointments Image Figure 9. Eye Solutions Image Figure 10. Gels Image Figure 11. Capsules & Tablets Image Figure 12. Global Ophthalmology Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Ophthalmology Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Ophthalmology Therapeutics Sales Market Share by Type (2021-2032) Figure 15. Global Ophthalmology Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Ophthalmology Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Ophthalmology Therapeutics Revenue Market Share by Type (2021-2032) Figure 18. Eye Infection Image Figure 19. Glaucoma Image Figure 20. Dry Eye Syndrome Image Figure 21. Other Image Figure 22. Global Ophthalmology Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Ophthalmology Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ophthalmology Therapeutics Sales Market Share by Application (2021-2032) Figure 25. Global Ophthalmology Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Ophthalmology Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Ophthalmology Therapeutics Revenue Market Share by Application (2021-2032) Figure 28. North America Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Ophthalmology Therapeutics Sales Market Share by Country (2021-2032) Figure 30. U.S. Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Ophthalmology Therapeutics Sales Market Share by Country (2021-2032) Figure 35. Germany Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Ophthalmology Therapeutics Sales Market Share by Country (2021-2032) Figure 42. China Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Ophthalmology Therapeutics Sales Market Share by Country (2021-2032) Figure 50. Brazil Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Ophthalmology Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Ophthalmology Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Ophthalmology Therapeutics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Ophthalmology Therapeutics Revenue (2021-2032) & (US$ Million) Figure 61. North America Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Ophthalmology Therapeutics Revenue (2021-2032) & (US$ Million) Figure 63. Europe Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Ophthalmology Therapeutics Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Ophthalmology Therapeutics Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Ophthalmology Therapeutics Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Ophthalmology Therapeutics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Eye Solutions
  • Gels
  • Capsules & Tablets
Applications
  • Eye Infection
  • Glaucoma
  • Dry Eye Syndrome
  • Other
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis AG
  • Pfizer
  • Santen Pharmaceutical
  • Bayer
  • AbbVie
  • Regeneron Pharmaceuticals
  • Otsuka Holdings
  • F. Hoffmann-La Roche
  • Aerie Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ophthalmology Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ophthalmology Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ophthalmology Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ophthalmology Therapeutics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ophthalmology Therapeutics Market Dynamics
  1. 2.1 Ophthalmology Therapeutics Industry Trends
  2. 2.2 Ophthalmology Therapeutics Industry Drivers
  3. 2.3 Ophthalmology Therapeutics Industry Opportunities and Challenges
  4. 2.4 Ophthalmology Therapeutics Industry Restraints
3 Ophthalmology Therapeutics Market by Manufacturers
  1. 3.1 Global Ophthalmology Therapeutics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ophthalmology Therapeutics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ophthalmology Therapeutics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ophthalmology Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmology Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ophthalmology Therapeutics Manufacturers, Product Type & Application
  7. 3.7 Global Ophthalmology Therapeutics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmology Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmology Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmology Therapeutics Tier 1, Tier 2, and Tier 3
4 Ophthalmology Therapeutics Market by Type
  1. 4.1 Ophthalmology Therapeutics Type Introduction
  2. 4.1.1 Ointments
  3. 4.1.2 Eye Solutions
  4. 4.1.3 Gels
  5. 4.1.4 Capsules & Tablets
  6. 4.2 Global Ophthalmology Therapeutics Sales by Type
  7. 4.2.1 Global Ophthalmology Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ophthalmology Therapeutics Sales by Type (2021-2032)
  9. 4.2.3 Global Ophthalmology Therapeutics Sales Market Share by Type (2021-2032)
  10. 4.3 Global Ophthalmology Therapeutics Revenue by Type
  11. 4.3.1 Global Ophthalmology Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ophthalmology Therapeutics Revenue by Type (2021-2032)
  13. 4.3.3 Global Ophthalmology Therapeutics Revenue Market Share by Type (2021-2032)
5 Ophthalmology Therapeutics Market by Application
  1. 5.1 Ophthalmology Therapeutics Application Introduction
  2. 5.1.1 Eye Infection
  3. 5.1.2 Glaucoma
  4. 5.1.3 Dry Eye Syndrome
  5. 5.1.4 Other
  6. 5.2 Global Ophthalmology Therapeutics Sales by Application
  7. 5.2.1 Global Ophthalmology Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ophthalmology Therapeutics Sales by Application (2021-2032)
  9. 5.2.3 Global Ophthalmology Therapeutics Sales Market Share by Application (2021-2032)
  10. 5.3 Global Ophthalmology Therapeutics Revenue by Application
  11. 5.3.1 Global Ophthalmology Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ophthalmology Therapeutics Revenue by Application (2021-2032)
  13. 5.3.3 Global Ophthalmology Therapeutics Revenue Market Share by Application (2021-2032)
6 Global Ophthalmology Therapeutics Sales by Region
  1. 6.1 Global Ophthalmology Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmology Therapeutics Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmology Therapeutics Sales by Region (2021-2026)
  4. 6.2.2 Global Ophthalmology Therapeutics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ophthalmology Therapeutics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ophthalmology Therapeutics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ophthalmology Therapeutics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ophthalmology Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ophthalmology Therapeutics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ophthalmology Therapeutics Revenue by Region
  1. 7.1 Global Ophthalmology Therapeutics Revenue by Region
  2. 7.1.1 Global Ophthalmology Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ophthalmology Therapeutics Revenue by Region (2021-2026)
  4. 7.1.3 Global Ophthalmology Therapeutics Revenue by Region (2027-2032)
  5. 7.1.4 Global Ophthalmology Therapeutics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ophthalmology Therapeutics Revenue (2021-2032)
  8. 7.2.2 North America Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ophthalmology Therapeutics Revenue (2021-2032)
  11. 7.3.2 Europe Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ophthalmology Therapeutics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ophthalmology Therapeutics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ophthalmology Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Ophthalmology Therapeutics Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Ophthalmology Therapeutics Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Santen Pharmaceutical
  20. 8.4.1 Santen Pharmaceutical Company Information
  21. 8.4.2 Santen Pharmaceutical Business Overview
  22. 8.4.3 Santen Pharmaceutical Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Santen Pharmaceutical Ophthalmology Therapeutics Product Portfolio
  24. 8.4.5 Santen Pharmaceutical Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Ophthalmology Therapeutics Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Ophthalmology Therapeutics Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Regeneron Pharmaceuticals
  38. 8.7.1 Regeneron Pharmaceuticals Company Information
  39. 8.7.2 Regeneron Pharmaceuticals Business Overview
  40. 8.7.3 Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Portfolio
  42. 8.7.5 Regeneron Pharmaceuticals Recent Developments
  43. 8.8 Otsuka Holdings
  44. 8.8.1 Otsuka Holdings Company Information
  45. 8.8.2 Otsuka Holdings Business Overview
  46. 8.8.3 Otsuka Holdings Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Otsuka Holdings Ophthalmology Therapeutics Product Portfolio
  48. 8.8.5 Otsuka Holdings Recent Developments
  49. 8.9 F. Hoffmann-La Roche
  50. 8.9.1 F. Hoffmann-La Roche Company Information
  51. 8.9.2 F. Hoffmann-La Roche Business Overview
  52. 8.9.3 F. Hoffmann-La Roche Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 F. Hoffmann-La Roche Ophthalmology Therapeutics Product Portfolio
  54. 8.9.5 F. Hoffmann-La Roche Recent Developments
  55. 8.10 Aerie Pharmaceuticals
  56. 8.10.1 Aerie Pharmaceuticals Company Information
  57. 8.10.2 Aerie Pharmaceuticals Business Overview
  58. 8.10.3 Aerie Pharmaceuticals Ophthalmology Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aerie Pharmaceuticals Ophthalmology Therapeutics Product Portfolio
  60. 8.10.5 Aerie Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmology Therapeutics Value Chain Analysis
  2. 9.1.1 Ophthalmology Therapeutics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmology Therapeutics Production Mode & Process
  6. 9.2 Ophthalmology Therapeutics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmology Therapeutics Distributors
  9. 9.2.3 Ophthalmology Therapeutics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst